Point72 (Difc) LTD Rapt Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 8,697 shares of RAPT stock, worth $26,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,697
Previous 51,529
83.12%
Holding current value
$26,960
Previous $463 Million
94.27%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
124Shares Held
29.1MCall Options Held
903KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$9.64 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$8.31 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$7.56 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$5.35 Million0.61% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$4.96 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $91.9M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...